Collectively, these findings enhance our understanding of the role of FOLH1/PSMA in prostate cancer biology and its potential as a multifaceted molecular indicator to inform prognosis and therapeutic strategies in prostate cancer. This evidence concerns the gene FOLH1 and Familial prostate cancer.